Abstract
The report covers a forecast and an analysis of the surgical tumor ablation market on a global and regional level. The study provides historical data from 2017 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes the drivers and restraints of the surgical tumor ablation market along with their impact on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the surgical tumor ablation market on a global level.
In order to give the users of this report a comprehensive view of the surgical tumor ablation market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.
The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new technology launch, agreements, partnerships, collaborations & joint ventures, research & development, technology, and regional expansion of major participants involved in the market on a global and regional basis. Moreover, the study covers price trend analysis and product portfolio of various companies according to regions.
The study provides a decisive view of the surgical tumor ablation market by segmenting it based on technology, application, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025. The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Some key players of the global surgical tumor ablation market are Galil Medical, Misonix, HealthTronics, AngioDynamics, Covidien, Boston Scientific Corporation, Medtronic, SonaCare Medical, EDAP TMS, and NeuWave Medical.
This report segments the global surgical tumor ablation market into:
Global Surgical Tumor Ablation Market: Technology Analysis
Radiofrequency Ablation
Microwave Ablation
Cryoablation
Others
Global Surgical Tumor Ablation Market: Application Analysis
Liver Cancer
Breast Cancer
Lung Cancer
Prostate Cancer
Others
Global Surgical Tumor Ablation Market: Regional Analysis
North America
The U.S.
Europe
UK
France
Germany
Asia Pacific
China
Japan
India
Latin America
Brazil
Middle East and Africa